GM Advisory Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,200
Closed -$218K 125
2019
Q3
$218K Hold
2,200
0.07% 98
2019
Q2
$203K Hold
2,200
0.06% 105
2019
Q1
$208K Sell
2,200
-2,984
-58% -$261K 0.07% 101
2018
Q4
$332K Hold
5,184
0.12% 70
2018
Q3
$464K Hold
5,184
0.15% 66
2018
Q2
$412K Hold
5,184
0.12% 74
2018
Q1
$462K Sell
5,184
-120
-2% -$11.5K 0.14% 66
2017
Q4
$554K Buy
5,304
+2,200
+71% +$248K 0.15% 64
2017
Q3
$453K Sell
3,104
-104
-3% -$14.2K 0.14% 66
2017
Q2
$417K Buy
3,208
+104
+3% +$12.7K 0.13% 72
2017
Q1
$386K Hold
3,104
0.13% 69
2016
Q4
$359K Buy
+3,104
New +$346K 0.13% 77
2015
Q1
Sell
-2,664
Closed -$298K 85
2014
Q4
$298K Sell
2,664
-36
-1% -$3.8K 0.16% 47
2014
Q3
$256K Hold
2,700
0.19% 56
2014
Q2
$232K Buy
+2,700
New +$205K 0.2% 61
2014
Q1
Sell
-2,710
Closed -$229K 90
2013
Q4
$229K Buy
+2,710
New +$214K 0.24% 55

Other funds holding CELG

GM Advisory Group's CELG Position: Q4 2019 in Review

GM Advisory Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,200 shares — an estimated $218K sold.

GM Advisory Group first reported a position in CELG in Q4 2013 and held it in 16 quarters. The position peaked at $554K in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • GM Advisory Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • GM Advisory Group sold 2,200 Celgene Corp shares in Q4 2019, an estimated $218K.
  • GM Advisory Group first reported a position in Celgene Corp in Q4 2013 and held it in 16 quarters.
  • GM Advisory Group's Celgene Corp position peaked at $554K in Q4 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on GM Advisory Group's 13F filing for Q4 2019, filed 14 Feb 2020.